Financials data is unavailable for this security.
View more
Year on year Cynata Therapeutics Ltd grew revenues 18.38% from 352.87k to 417.71k while net income improved from a loss of 14.28m to a smaller loss of 9.74m.
| Gross margin | -- |
|---|---|
| Net profit margin | -2,332.89% |
| Operating margin | -2,349.11% |
| Return on assets | -71.18% |
|---|---|
| Return on equity | -81.37% |
| Return on investment | -81.37% |
More ▼
Cash flow in AUDView more
In 2024, cash reserves at Cynata Therapeutics Ltd fell by 9.96m. Cash Flow from Financing was even, which indicates that this company's capital needs are balanced. In addition the company used 9.96m for operations while cash used for investing totalled .
| Cash flow per share | -0.0527 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 0.0402 |
|---|---|
| Tangible book value per share | 0.0299 |
More ▼
Balance sheet in AUDView more
| Current ratio | 5.58 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | 0.00 |
|---|---|
| Total debt/total capital | 0.00 |
More ▼
